Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Baoyue Pan
Observed name:
Pan, Baoyue
Institutions:
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
Observed institutions:
Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China
ORCID:
0000-0001-5922-7136
Observed ORCID:
0000-0001-5922-7136
OpenAlex ID:
A5036305329
Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
2022
·
Pingping Liu
, Yinan Jiang
, et al.
·
Pathology & Oncology Research
·
40
The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophages
2023
·
Baoyue Pan
, Ting Wan
, et al.
·
Cancer Cell International
·
34
PDF
Methyltransferase‐like 3 promotes cervical cancer metastasis by enhancing cathepsin L mRNA stability in an N6‐methyladenosine‐dependent manner
2022
·
Pingping Liu
, Mingxiu Ju
, et al.
·
Cancer Science
·
22
PDF
Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix
2024
·
Baoyue Pan
, Shumei Yan
, et al.
·
The Journal of Pathology
·
20
Tislelizumab for cervical cancer: A retrospective study and analysis of correlative blood biomarkers
2023
·
Xiaojing Zheng
, Haifeng Gu
, et al.
·
Frontiers in Immunology
·
13
PDF
Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer
2021
·
Yinan Jiang
, Haifeng Gu
, et al.
·
Pathology & Oncology Research
·
13
PDF
The comparison of efficacy and safety between cadonilimab (PD-1/CTLA-4) and anti-PD-1 inhibitors in patients with recurrent or metastatic cervical cancer: a retrospective real-world study
2025
·
Baoyue Pan
, He Huang
, et al.
·
Frontiers in Immunology
·
11
PDF
A Nomogram for Preoperative Prediction of the Risk of Lymph Node Metastasis in Patients with Epithelial Ovarian Cancer
2023
·
Huiling Xiang
, Fan Yang
, et al.
·
Current Oncology
·
11
PDF
Targeting the Cdc2‐like kinase 2 for overcoming platinum resistance in ovarian cancer
2024
·
Yinan Jiang
, Shuting Huang
, et al.
·
MedComm
·
10
PDF
The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer
2024
·
Mingxiu Ju
, Baoyue Pan
, et al.
·
Cancer Medicine
·
8
PDF
Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer
2022
·
Baoyue Pan
, Ting Wan
, et al.
·
BMC Cancer
·
8
PDF
The efficacy and peripheral blood predictors in recurrent platinum-resistant ovarian cancer patients treated with immune checkpoint inhibitors
2025
·
Baoyue Pan
, Xiaojing Zheng
, et al.
·
Journal of Ovarian Research
·
2
PDF
The efficacy and safety of cadonilimab after first anti-PD-1 failure in the treatment of recurrent endometrial and cervical carcinoma: A retrospective, real-world study
2024
·
Baoyue Pan
, Min Zheng
·
Gynecologic Oncology
·
1
PT002/#568 Cadonilimab in combination with disitamab vedotin or nab-paclitaxel in the treatment of recurrent or metastatic cervical cancer: a prospective, double-cohort, multi-center, open-label, phase II clinical study (AK001)
2024
·
Haifeng Gu
, Jian Zhou
, et al.
·
International Journal of Gynecological Cancer
·
1
NFKB1 nuclear translocation induced by KPNA2 enhances CXCL10-mediated immune suppression in ovarian cancer
2026
·
Shijie Xu
, Lan Zhang
, et al.
·
Genes & Diseases
PDF
Efficacy and safety of cadonilimab (CD) in combination with disitamab vedotin (RC48) or nab-paclitaxel (NP) in the treatment of recurrent or metastatic cervical cancer (r/mCC): A prospective, double-cohort, multicenter, open-label, phase II clinical study.
2026
·
Min Zheng
, Haifeng Gu
, et al.
·
Journal of Clinical Oncology
ACY1-mediated deacetylation of GSTP1 at lysine 30 suppresses cisplatin resistance in epithelial ovarian cancer
2022
·
Min Zheng
, Xiaojing Zheng
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
21
Citation count:
194
H-index:
9
I10-index:
9
Year
Topic
Type